These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 29776198)

  • 1. Assigning value to medical algorithms: implications for personalized medicine.
    Hornberger J
    Per Med; 2013 Aug; 10(6):577-588. PubMed ID: 29776198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modernizing US regulatory and reimbursement policy to support continued innovation in genomic pathology.
    Walcoff SD; Pfeifer JD
    Per Med; 2012 May; 9(3):295-308. PubMed ID: 29758795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bringing personalized medicine to the community through public engagement.
    Etchegary H; Wilson B
    Per Med; 2013 Sep; 10(7):647-659. PubMed ID: 29768762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doctors in society. Medical professionalism in a changing world.
    Working Party of the Royal College of Physicians
    Clin Med (Lond); 2005; 5(6 Suppl 1):S5-40. PubMed ID: 16408403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Personal genomics: are we debating the right Issues?].
    Vayena E; Mauch F
    Praxis (Bern 1994); 2012 Jul; 101(15):961-4. PubMed ID: 22811328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision technologies as normative instruments: exposing the values within.
    Boivin A; Légaré F; Lehoux P
    Patient Educ Couns; 2008 Dec; 73(3):426-30. PubMed ID: 18774669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
    Ahmed MU; Saaem I; Wu PC; Brown AS
    Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing 15D Valuation Studies in Norway and Finland-Challenges When Combining Information from Several Valuation Tasks.
    Michel YA; Augestad LA; Rand K
    Value Health; 2018 Apr; 21(4):462-470. PubMed ID: 29680104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive IT-systems for big data analysis in medicine.
    Isakova J
    Int J Risk Saf Med; 2015; 27 Suppl 1():S108-9. PubMed ID: 26639685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing guidance for genomics-based cancer treatment decisions: insights from stakeholder engagement for post-prostatectomy radiation therapy.
    Abe J; Lobo JM; Trifiletti DM; Showalter TN
    BMC Med Inform Decis Mak; 2017 Aug; 17(1):128. PubMed ID: 28836985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interprofessional education for personalized medicine through technology-based learning.
    Haga SB; Mills R; Aucoin J; Taekman J
    Per Med; 2015 Jun; 12(3):237-243. PubMed ID: 29771651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecosystem valuation: a sequential decision support system and quality assessment issues.
    Turner RK; Morse-Jones S; Fisher B
    Ann N Y Acad Sci; 2010 Jan; 1185():79-101. PubMed ID: 20146763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying high-dimensional biomarkers for personalized medicine via variable importance ranking.
    Baek S; Moon H; Ahn H; Kodell RL; Lin CJ; Chen JJ
    J Biopharm Stat; 2008; 18(5):853-68. PubMed ID: 18781521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine: reality and reality checks.
    Leeder JS; Spielberg SP
    Ann Pharmacother; 2009 May; 43(5):963-6. PubMed ID: 19417116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic translational research: Paving the way to individualized cardiac functional analyses and personalized cardiology.
    Pasipoularides A
    Int J Cardiol; 2017 Mar; 230():384-401. PubMed ID: 28057368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice.
    Geller G; Dvoskin R; Thio CL; Duggal P; Lewis MH; Bailey TC; Sutherland A; Salmon DA; Kahn JP
    Genome Med; 2014; 6(11):106. PubMed ID: 25593592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsustainable Growth, Hyper-Competition, and Worth in Life Science Research: Narrowing Evaluative Repertoires in Doctoral and Postdoctoral Scientists' Work and Lives.
    Fochler M; Felt U; Müller R
    Minerva; 2016; 54():175-200. PubMed ID: 27340295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.